BODI
The Beachbody Company, Inc.
BODI trails on the overall score without a compensating advantage in the available component scores.
RDDT
Reddit, Inc.
RDDT has the edge over BODI overall, supported by stronger fundamentals and lower modeled downside.
BODI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
BODI's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
RDDT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
RDDT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BODI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.1x | $3.25 | — |
| Cheap | 2.6x | $4.11 | +27% |
| Fair | 4.1x | $6.41 | +97% |
| Expensive | 15x | $22.97 | +607% |
Historical ranges are pointers, not guarantees.
BODI has the edge over RDDT in the historical PE scenario, which offers more potential upside but is not a forecast.
RDDT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $99.55 | — |
| Current | 20x | $99.55 | — |
| Cheap | 35x | $171 | +72% |
| Fair | 46x | $228 | +129% |
| Expensive | 53x | $262 | +163% |
Historical ranges are pointers, not guarantees.
RDDT's PE is 20x, but its earnings don't support one, so it isn't a reliable read right now.
BODI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect BODI's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
RDDT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
RDDT has the edge over BODI on the outlook, with more favorable revenue expectations.
BODI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.56 | +$7.81 |
| Q2 2026 | $1.69 | +$10.20 |
| Q1 2026 | $0.73 | +$9.98 |
| Q4 2025 | -$0.41 | +$10.10 |
| Q3 2025 | -$6.25 | +$9.66 |
| Q2 2025 | -$8.51 | +$11.15 |
| Q1 2025 | -$9.25 | +$12.82 |
| Q4 2024 | -$10.51 | +$13.96 |
RDDT has the stronger earnings trend. Trailing diluted EPS is down 75% for BODI versus RDDT down 39%.
RDDT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.32 | +29% |
| Q3 2024 | -$7.98 | -$7.17 |
| Q2 2024 | -$8.19 | -$7.15 |
| Q1 2024 | -$8.38 | -$7.25 |
| Q4 2023 | -$0.56 | +$0.41 |
| Q3 2023 | -$0.81 | -$0.02 |
| Q2 2023 | -$1.04 | -$0.48 |
| Q1 2023 | -$1.13 | -$0.48 |
| Q4 2022 | -$0.97 | -$0.19 |
RDDT has returned to profit: it earned $4.90 per share over the past year, after losing money the year before.
BODI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.2M | -25% |
| Q2 2026 | $49.6M | -22% |
| Q1 2026 | $54.3M | -25% |
| Q4 2025 | $55.5M | -36% |
| Q3 2025 | $59.9M | -41% |
| Q2 2025 | $63.9M | -42% |
| Q1 2025 | $72.4M | -40% |
| Q4 2024 | $86.4M | -27% |
BODI's revenue has slid since its 2020 peak: $45M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -5.4 points |
| Q2 2026 | 3.4% | +9.6 points |
| Q1 2026 | 5.7% | +11 points |
| Q4 2025 | 15% | +53 points |
| Q3 2025 | 8.3% | +21 points |
| Q2 2025 | -6.2% | +2.4 points |
| Q1 2025 | -5.1% | +3.9 points |
| Q4 2024 | -38% | +13 points |
BODI's operating margin was 2.9% last quarter, down 5.4 points from the same quarter a year ago.
RDDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $895M | +53% |
| Q2 2026 | $804.9M | +61% |
| Q1 2026 | $663.4M | +69% |
| Q4 2025 | $725.6M | +70% |
| Q3 2025 | $584.9M | +68% |
| Q2 2025 | $499.6M | +78% |
| Q1 2025 | $392.4M | +61% |
| Q4 2024 | $427.7M | +71% |
RDDT has the edge over BODI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +5.5 points |
| Q2 2026 | 29% | +15 points |
| Q1 2026 | 28% | +27 points |
| Q4 2025 | 32% | +20 points |
| Q3 2025 | 24% | +22 points |
| Q2 2025 | 14% | +25 points |
| Q1 2025 | 1% | +244 points |
| Q4 2024 | 12% | +11 points |
RDDT has the edge over BODI on profitability, with a higher operating margin.
BODI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | -171% |
| Q2 2026 | -$4M | -265% |
| Q1 2026 | -$1.7M | -205% |
| Q4 2025 | $4.3M | +$11.6M |
| Q3 2025 | $9M | +16881% |
| Q2 2025 | $2.4M | +$4.6M |
| Q1 2025 | $1.6M | -78% |
| Q4 2024 | -$7.3M | +$1.7M |
BODI has burned cash in most quarters: −$8M over the past year, against $6M the year before.
RDDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $362.6M | +98% |
| Q2 2026 | $260.7M | +135% |
| Q1 2026 | $311.2M | +146% |
| Q4 2025 | $263.6M | +196% |
| Q3 2025 | $183.1M | +161% |
| Q2 2025 | $110.8M | +308% |
| Q1 2025 | $126.6M | +333% |
| Q4 2024 | $89.2M | +$111.2M |
RDDT has the edge over BODI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BODI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.2% | -487K shares |
| 1 year | +5.3% | +372K shares |
| 3 years | +20% | +1.2M shares |
| 5 years | +22% | +1.3M shares |
BODI has 7M diluted shares, up 5.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
RDDT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -169K shares |
| 1 year | -0.4% | -868K shares |
| 3 years | +24% | +38.5M shares |
| 5 years | +24% | +38.5M shares |
RDDT has the edge over BODI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.4M |
| Q2 2026 | $234.6M |
| Q1 2026 | $5M |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $4.2M |
| Q4 2022 | — |
BODI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2020 | -1.0x | Net Cash |
BODI has more cash than debt.
RDDT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.5x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -3.3x | Net Cash |
| Q2 2025 | -5.0x | Net Cash |
| Q1 2025 | -13.1x | Net Cash |
RDDT has the edge over BODI on leverage, with a lower net debt burden relative to earnings.
BODI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 2.2 | Oversold |
BODI's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
RDDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 6.5 | Oversold |
RDDT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
BODI PE vs Communication Services Sector
| Metric | BODI | Sector median | Relative |
|---|---|---|---|
| PE | 2.1x | 16x | 87% below |
| PE % | 0 | 28 | 28 pts below |
BODI has the edge over RDDT on valuation relative to its sector.
RDDT PE vs Communication Services Sector
| Metric | RDDT | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 16x | 23% above |
| PE % | 5 | 23 | 18 pts below |
RDDT is trading at 20x earnings, a 23% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
BODI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 25% below |
| 20 week MA | $6.65 | 51% below |
| 50 week MA | $9.06 | 64% below |
| 100 week MA | $7.32 | 56% below |
| 200 week MA | $10.8 | 70% below |
RDDT has stronger trend alignment. BODI is above 0 of 5 weekly averages versus RDDT above 0 of 4.
RDDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $130.6 | 24% below |
| 20 week MA | $151.7 | 34% below |
| 50 week MA | $165.0 | 40% below |
| 100 week MA | $167.1 | 40% below |
RDDT is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.
BODI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $523.5 | $126.0 | -76% |
| 2022 | $126.0 | $27.3 | -78% |
| 2023 | $27.3 | $8.29 | -70% |
| 2024 | $8.29 | $6.07 | -27% |
| 2025 | $6.07 | $10.1 | +66% |
| 2026 YTD | $10.1 | $3.25 | -68% |
BODI has finished lower in four of the last five years. It's down 68% so far in 2026.
RDDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $46.0 | $173.5 | +277% |
| 2025 | $173.5 | $225.8 | +30% |
| 2026 YTD | $225.8 | $99.6 | -56% |
RDDT has the edge over BODI on returns for 2026, with the stronger performance.